Exploratory/Developmental Clinical Research Grants in Obesity (R21)

Exploratory/Developmental Clinical Research Grants in Obesity (R21)

Purpose: This FOA issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); the National Heart, Lung and Blood Institute (NHLBI); the National Cancer Institute (NCI); the National Center for Complementary and Alternative Medicine (NCCAM), Office of Dietary Supplements (ODS), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH), encourages research grant applications from institutions/organizations that propose to conduct exploratory/developmental clinical studies that will accelerate the development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.
Receipt Date: Cycle Due Dates (new submission): Feb. 16, June 16, Oct. 16
Expires: May 8, 2015
Total Awards: Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year. F&A costs requested by consortium participants are not included in the direct cost limitation.
Eligibility: Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Link: http://grants.nih.gov/grants/guide/pa-files/PA-12-179.html
Print Friendly